Reliability of whole crypt mitotic count as a measure of cellular proliferation in rectal biopsies

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 6, 1996, Pages 437-439

  Tosteson, Tor D ^a   Karagas, Margaret R ^a   Rothstein, Richard ^a   Ahnen, Dennis J ^b   Greenberg, E Robert ^a,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c NORRIS COTTON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER SCREENING; CELL PROLIFERATION; CLINICAL ARTICLE; COLON BIOPSY; COLORECTAL CANCER; CRYPT CELL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; MITOSIS INDEX; PRIORITY JOURNAL;

ADULT; AGED; CELL DIVISION; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MITOTIC INDEX; RECTUM; RISK;

EID: 0029944176     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lipkin, M., Bhandari, M., Hakissian, M., Croll, W., and Wong, G. Surrogate endpoint biomarker assay in Phase II chemoprevention clinical trials. J. Cell. Biochem., 19: 47-54, 1994.
2. Rozen, P. An evaluation of rectal epithelial proliferation measurement as biomarker of risk for colorectal neoplasia and response in intervention studies. Eur. J. Cancer Prev., 1: 215-224, 1992.
3. Greenwald, P., Kelloff, G. J., Boone, C. W., and McDonald, S. S. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol, Biomarkers & Prev., 4: 691-702, 1995.
4. Lipkin, M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res., 48: 235-245, 1988.
5. Cohen, S. M., and Ellwein, L. B. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res., 51: 6493-6505, 1991.
6. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., and Henderson, B. E. Increased cell division as a cause of human cancer. Cancer Res., 50: 7415-7421, 1990.
7. Farber, E. Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res., 55: 3759-3762, 1995.
8. Pohl, A., Weyant, J., and Ahnen, D. J. Validation of the whole crypt mitotic count (WCMC) as a measure of proliferation in the rat colon (Abstract). Gastroenterology, 102: A939, 1992.
9. Murray, S. C., Sandler, R. S., Keku, T. O., Lyles, C. M., Millikan, R. C., Bangdiwala, S. I., Kupper, L. L., Jiang, W., and Ulshen, M. H. Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection. Cancer Epidemiol, Biomarkers & Prev., 4: 715-720, 1995.
10. SAS Institute, Inc. SAS User's Guide. Basic. Cary, NC: SAS Institute, Inc., 1990.
11. Baron, J. A., Wargovich, M. J., Tosteson, T. D., Sandler, R., Haile, R., Summers, R., van Stolk, R., Rothstein, R., and Weiss, J. Epidemiological use of rectal proliferation measures. Cancer Epidemiol, Biomarkers & Prev., 4: 57-61, 1995.
12. h) labeling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res., 43: 1899-1904, 1983.
13. Bostick, R. M., Potter, J. D., Fosdick, L., Grambsch, P., Lampe, J. W., Wood, J. R., Louis, T. A., Ganz, R., and Grandits, G. Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial. J. Natl. Cancer Inst., 85: 132-141, 1993.
14. Lyles, C. M., Sandler, R. S., Keku, T. O., Kupper, L. L., Millikan, R. C., Murray, S. C., Bangdiwala, S. I., and Ulshen, M. H. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry. Cancer Epidemiol, Biomarkers & Prev., 3: 597-605, 1994.
15. Freedman, L. S., and Schatzkin, A. Sample size for studying intermediate endpoints within intervention trials or observational studies. Am. J. Epidemiol., 136: 1148-1159, 1992.